BioT™ ULT Transporter
< -70°C to -50°C Dry-Ice Based Temperature Stability System, Item No. MCS-518U
BioT™ ULT Transporter is a breakthrough portable solution for handling and transporting valuable temperature-sensitive frozen biosamples. The BioT™ ULT Transporter uses dry-ice based temperature stability to keep samples frozen during short-term transport or processing.
- Maintains < -70°C and -50°C for over 24 hours with minimal dry ice
- Ideal for freezing samples at a collection site.
- Holds up to 8 standard 2-inch cryostorage boxes or 18, 250 mL cassettes
- Lightweight, built-in finger grips for easy carrying
- Intuitive assembly, highly durable materials
Comprised of three parts: magnetized lid, DIR™ dry ice retainer and base chamber. The closed-cell high-density polyethylene foam construction of the lid and base chamber is durable, non-absorbent, and remains comfortable to the touch even when loaded with dry ice and frozen materials. The magnetized lid ensure safe transport of the contents. The DIR retainer is constructed of a thermo-conductive aluminum alloy anodized for durability.
Features & Specifications
BioT™ ULT Transporter
|Dimensions:||Internal working area: 29.0 x 16.2 x 20.3 cm (11.4 x 6.4 x 8.0 in) External: 50.8 x 33.8 x 33 cm (20.0 x 13.3 x 13 in)|
|-70°C to -50°C:||Lid off: over 8 hours / Lid on: over 24 hours|
|Amount of dry ice required:||5.4 kg (12.8 lb)|
|Weight empty:||3.6 kg (8.0 lb)|
|Weight with dry ice:||9.0 kg (20.8 lb)|
|Working depth < -50°C:||up to 20 cm (8 in) from chamber floor|
|Capacity:||8 standard 2-inch cryostorage boxes or 18, 250 mL cassettes|
BioT™ DIR™ retainer
|Dimensions:||36.5 x 20.3 x 23.5 cm (14.4 x 8.0 x 9.25 in)|
This product is for laboratory research use only. Any intended use for diagnostic purposes, direct transfusion, or in the production of therapeutic product(s) or vaccines(s) may require advance regulatory clearance which is the sole responsibility of the user, as this is not a medical device that has undergone medical device registration, clearance, or approval by the U.S. Food and Drug Administration (FDA), European Union, Health Canada, or the Australian Therapeutic Goods Administration.